A detailed history of Citigroup Inc transactions in Koru Medical Systems, Inc. stock. As of the latest transaction made, Citigroup Inc holds 19 shares of KRMD stock, worth $89. This represents 0.0% of its overall portfolio holdings.

Number of Shares
19
Previous 1,637 98.84%
Holding current value
$89
Previous $4,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$2.13 - $2.77 $3,446 - $4,481
-1,618 Reduced 98.84%
19 $0
Q2 2024

Aug 12, 2024

SELL
$2.06 - $2.99 $8,347 - $12,115
-4,052 Reduced 71.23%
1,637 $4,000
Q1 2024

May 10, 2024

BUY
$2.04 - $2.38 $1,536 - $1,792
753 Added 15.26%
5,689 $13,000
Q4 2023

Feb 09, 2024

BUY
$2.03 - $2.77 $9,930 - $13,550
4,892 Added 11118.18%
4,936 $12,000
Q3 2023

Nov 09, 2023

SELL
$2.37 - $3.52 $24,565 - $36,484
-10,365 Reduced 99.58%
44 $0
Q2 2023

Aug 10, 2023

BUY
$3.45 - $4.47 $35,911 - $46,528
10,409 New
10,409 $35,000

Others Institutions Holding KRMD

About KORU Medical Systems, Inc.


  • Ticker KRMD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 45,033,100
  • Market Cap $212M
  • Description
  • KORU Medical Systems, Inc. designs, manufactures, and markets portable medical devices primarily for the ambulatory infusion market in the United States and internationally. It offers mechanical infusion product comprising the FREEDOM infusion systems that include the FREEDOM60 syringe driver, the FreedomEdge syringe driver, HIgH-Flo subcutaneou...
More about KRMD
Track This Portfolio

Track Citigroup Inc Portfolio

Follow Citigroup Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Citigroup Inc, based on Form 13F filings with the SEC.

News

Stay updated on Citigroup Inc with notifications on news.